Faculty

Lana Dbeibo, MD, MPH

Associate Professor of Clinical Medicine

Email ldbeibo@iupui.edu

Address

545 Barnhill Dr.
Emerson Hall 421

Indianapolis, IN 46202-5124

Bio

After graduating medical school from the American University of Beirut, Dr. Dbeibo completed her residency in Internal Medicine and fellowship in Infectious Diseases at Indiana University School of Medicine. Dr. Dbeibo is currently the Medical Director of Infection Prevention at Methodist Hospital, and is the Associate Vice Chair for Clinical Affairs - Quality Safety and Population Health - for the Department of Medicine. She provides inpatient consults at Methodist Hospital.

Titles & Appointments

Associate Professor of Clinical Medicine
IUH Methodist Hospital Infection Prevention Medical Director

Education

2023 MPH IU Richard M. Fairbanks School of Public Health

2016 FEL Infectious Diseases Fellowship, Indiana University School of Medicine

2014 RES Internal Medicine Residency, Indiana University School of Medicine

2010 MD American University of Beirut

2006 BS American University of Beirut
Publications

In-person classroom instruction and risk of SARS-CoV-2 infection among undergraduates at Indiana University, Fall 2020.
Rosenberg M; Carroll AE; Menachemi N; Inman H; Agard A; Hiller KM; Dbeibo L; Journal of American college health : J of ACH 2023 Jan 3

Clinical comparison and agreement of PCR, antigen, and viral culture for the diagnosis of COVID-19: Clinical Agreement Between Diagnostics for COVID19.
Agard A; Elsheikh O; Bell D; Relich RF; Schmitt BH; Sadowski J; Fadel W; Webb DH; Dbeibo L; Kelley K; Carozza M; Lei GS; Calkins P; Beeler C; Journal of clinical virology plus 2022 Jul 21

Real world utilization of nurse-driven urinary catheter removal protocol in patients with epidural pain catheters.
Beeler C; Dbeibo L; Yeap YL; Porter H; Beeson T; Schmidt CM; House MG; Glossenger A; Kelley K; Birdas TJ; American journal of infection control 2021 Sep 20

Assessment of a universal preprocedural screening program for coronavirus disease 2019 (COVID-19).
Dbeibo L; Kuebler K; Keen A; George A; Kelley K; Sadowski J; Basham L; Beeson T; Schmidt CM; Beeler C; Webb D; Infection control and hospital epidemiology 2021 Feb 2

Use of an intraoperative sodium oxychlorosene-based infection prevention protocol to safely decrease postoperative wound infections after spine surgery.
Alentado VJ; Berwanger RP; Konesco AM; Potts AJ; Potts CA; Stockwell DW; Dbeibo L; DePowell JJ; Horn EM; Khairi SA; McCanna SP; Mobasser JP; Rodgers RB; Potts EA; Journal of neurosurgery. Spine 2021 Aug 20

Changing the culture of urine culturing: Utilizing Agile Implementation to improve diagnostic stewardship in the ICU.
Page S; Hazen D; Kelley K; Singh R; Rodgers RB; Brewer B; Sadowski J; Desai A; Beeler C; Webb D; Azar J; Dbeibo L; American journal of infection control 2020 Nov

Utilizing a real-time discussion approach to improve the appropriateness of Clostridioides difficile testing and the potential unintended consequences of this strategy.
Dbeibo L; Brinkman A; Beeler C; Fadel W; Snyderman W; Hatfield N; Sadowski J; Wang Y; Kelley K; Webb D; Azar J; Kara A; Infection control and hospital epidemiology 2020 Jun 29

Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19.
Gavin W; Campbell E; Zaidi SA; Gavin N; Dbeibo L; Beeler C; Kuebler K; Abdel-Rahman A; Luetkemeyer M; Kara A; American journal of infection control 2020 Jul 8

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L; Infection control and hospital epidemiology 2020 Aug 3

Strategies for the successful implementation of disinfecting port protectors to reduce CLABSI in a large tertiary care teaching hospital.
Beeler C; Kerley D; Davis C; Hazen D; Snyderman W; Lyons K; Sadowski J; Sweeney J; Dbeibo L; Kelley K; Webb DH; American journal of infection control 2019 Jul 16

Achieving <i>Clostridioides difficile</i> infection Health and Human Services 2020 goals: Using agile implementation to bring evidence to the bedside.
Dbeibo L; Kelley K; Beeler C; Kara A; Monahan P; Perkins AJ; Wang Y; Brinkman A; Snyderman W; Hatfield N; Wrin J; Miller J; Webb D; Azar J; Infection control and hospital epidemiology 2019 Dec 5

Using the agile implementation model to reduce central line-associated bloodstream infections.
Azar J; Kelley K; Dunscomb J; Perkins A; Wang Y; Beeler C; Dbeibo L; Webb D; Stevens L; Luektemeyer M; Kara A; Nagy R; Solid CA; Boustani M; American journal of infection control 2018 Sep 7

Why do clinicians order inappropriate Clostridium difficile testing? An exploratory study.
Kara A; Tahir M; Snyderman W; Brinkman A; Fadel W; Dbeibo L; American journal of infection control 2018 Nov 2

Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.
Dbeibo L; van Rensburg JJ; Smith SN; Fortney KR; Gangaiah D; Gao H; Marzoa J; Liu Y; Mobley HLT; Spinola SM; Infection and immunity 2018 Feb 20

Assessing patient risk of central line-associated bacteremia via machine learning.
Beeler C; Dbeibo L; Kelley K; Thatcher L; Webb D; Bah A; Monahan P; Fowler NR; Nicol S; Judy-Malcolm A; Azar J; American journal of infection control 2018 Apr 13

Frequency of atazanavir-associated leukocyturia development and renal function decline.
Dbeibo L; Arif S; He F; Gupta SK; AIDS (London, England) 2016 Jun 1
Professional Organizations

Alpha Omega Alpha Honor Medical Society
Board Certifications

American Board of Internal Medicine - Infectious Disease
Awards

Org: Indiana University
Desc: Distinguished Service Medal
Scope: University
Date: 1905-07-15

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor